Preventing Diabetes in Mice with Gene Therapy
Author Information
Author(s): RAHUL M. JINDAL, M. KARANAM, RITA SHAH
Primary Institution: Indiana University School of Medicine; University of Glasgow
Hypothesis
Can intra-muscular injection of a recombinant adeno-associated virus containing the preproinsulin II gene prevent diabetes in NOD mice?
Conclusion
The study found that gene therapy using an insulin gene delivered via a virus can prevent diabetes in most treated mice.
Supporting Evidence
- 70% of the experimental group maintained euglycemic levels compared to 10% of the control group at 14 weeks.
- Mean weight in the treated group was greater than the untreated group.
- Insulin mRNA was detected at the injection site of all treated animals.
Takeaway
Scientists injected a special virus with an insulin gene into mice to help them not get diabetes, and it worked for most of the mice.
Methodology
NOD mice were injected with a recombinant adeno-associated virus containing the insulin gene and monitored for blood glucose levels over 16 weeks.
Limitations
The study did not determine the exact processing of the insulin produced from the gene therapy.
Participant Demographics
11-week-old female NOD mice
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website